BRADLEY PHARMACEUTICALS

(Redirected from Bradley Pharmaceuticals)

'Bradley Pharmaceuticals' is a Pharmaceutical company headquartered in Fairfield Township, Essex County, New Jersey. The company was founded in 1985 by Daniel Glassman who is at the current time its CEO.
The company markets to niche physician specialties in the U.S. and 38 international markets. Bradley Pharmaceuticals is comprised of Doak Dermatologics, specializing in therapies for dermatology and podiatry; Kenwood Therapeutics, providing gastroenterology, OB/GYN and other internal medicine brands; and A. Aarons, which markets authorized generic versions of Doak and Kenwood therapies.

Contents
Doak Dermatologics
Kenwood Therapeutics
Public Trading

Doak Dermatologics


Doak Dermatologics is the division of Bradley Pharmaceuticals that markets products to dermatologist. Its flag products are Zoderm which is a topical anti-acne product. Adoxa (doxycycline) is an antibiotic intended to treat mild to severe acne.

Kenwood Therapeutics


Kenwood is the affiliate brand that works with therapeutic products. Among the most prescribed ones are Entsol which is a respiratory therapeutic product and Pamine which is intended to treat digestive problems.

Public Trading


The company is publicly traded at the NYSE by its code BDY since May 2003.

This article provided by Wikipedia. To edit the contents of this article, click here for original source.

psst.. try this: add to faves